{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:54:24Z","timestamp":1784350464107,"version":"3.55.0"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013348","name":"Innosuisse - Schweizerische Agentur f\u00fcr Innovationsf\u00f6rderung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Digit. Health"],"abstract":"<jats:p>Digital biomarkers are revolutionizing medicine in ways that were unimaginable a few years ago. Consequently, precision medicine approaches now realistically can promise personalization, i.e., the right treatments for the right patients at the right time, including earlier, targeted interventions which lead to a major paradigm shift in how medicine is practiced from reactive to preventive action. Although the scientific evidence is clear on the power of digital biomarkers, there is an unmet need for translating these findings into actionable insights in clinical practice. In this paper, we focus on Alzheimer's disease and related dementias (ADRD), and how digital biomarkers could empower clinical decision making in its preclinical stages. We argue that a new all-encompassing score is needed, akin to a BrainHealth Index linked to the established and validated risk stratifications frameworks and is directed at the prevention of ADRD. Specifically, we propose the new concept \u201cDigital Neuro Fingerprint (DNF)\u201d, built with simultaneous collection of multimodal digital biomarkers (speech, gait, eye movements etc.) from smartphone based augmented reality or virtual reality while an individual is immersed in activities of daily living. Fusing the captured multimodal digital biomarkers, data is automatically analyzed with custom combinations of machine- and deep-learning approaches and enhanced with explainable artificial intelligence (XAI) and uncertainty quantifications. We argue that DNF is useful for capturing ADRD progression and should supersede the biomarkers that are invasive and expensive to obtain, offering a sensitive and highly specific score that measures meaningful aspects of health for the patients in high-frequency intervals.<\/jats:p>","DOI":"10.3389\/fdgth.2025.1727707","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:13:28Z","timestamp":1768205608000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Merging multimodal digital biomarkers into \u201cDigital Neuro Fingerprints\u201d for precision neurology in dementias: the promise of the right treatment for the right patient at the right time in the age of AI"],"prefix":"10.3389","volume":"7","author":[{"given":"Ioannis","family":"Tarnanas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azizi","family":"Seixas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wyss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Vlamos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"\u00c7\u00f6ltekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3233\/JAD-2010-1337","article-title":"Early-versus late-onset Alzheimer\u2019s disease: more than age alone","volume":"19","author":"Koedam","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1212\/WNL.0000000000009058","article-title":"Biological subtypes of Alzheimer disease: a systematic review and meta-analysis","volume":"94","author":"Ferreira","year":"2020","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3233\/JAD-191227","article-title":"The amyloid, tau, and neurodegeneration (A\/T\/N) classification applied to a clinical research cohort with long-term follow-up","volume":"74","author":"Gr\u00f8ntvedt","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s40478-022-01471-z","article-title":"The hippocampal sparing subtype of Alzheimer\u2019s disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review","volume":"10","author":"Ferreira","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e16302","DOI":"10.1111\/ene.16302","article-title":"What is Alzheimer\u2019s disease? An analysis of nosological perspectives from the 20th and 21st centuries","volume":"31","author":"Villain","year":"2024","journal-title":"Eur J Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e095134","DOI":"10.1002\/alz.095134","article-title":"Neurofibrillary tangle characterization in the olfactory bulb among clinicopathologic subtypes of Alzheimer\u2019s disease","volume":"20","author":"Chalk","year":"2024","journal-title":"Alzheimers Dement"},{"key":"B7","doi-asserted-by":"publisher","first-page":"102476","DOI":"10.1016\/j.arr.2024.102476","article-title":"Recent advancement in understanding of Alzheimer\u2019s disease: risk factors, subtypes, and drug targets and potential therapeutics","volume":"101","author":"Prabha","year":"2024","journal-title":"Ageing Res Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s43587-023-00550-7","article-title":"Cerebrospinal fluid proteomics in patients with Alzheimer\u2019s disease reveals five molecular subtypes with distinct genetic risk profiles","volume":"4","author":"Tijms","year":"2024","journal-title":"Nat Aging"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100467","DOI":"10.1016\/j.xcrm.2021.100467","article-title":"Subtyping of mild cognitive impairment using a deep learning model based on brain atrophy patterns","volume":"2","author":"Kwak","year":"2021","journal-title":"Cell Rep Med"},{"key":"B10","year":""},{"key":"B11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13195-017-0268-4","article-title":"Stem cell models of Alzheimer\u2019s disease: progress and challenges","volume":"9","author":"Arber","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13024-018-0258-4","article-title":"2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling","volume":"13","author":"Centeno","year":"2018","journal-title":"Mol Neurodegener"},{"key":"B13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"B14","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s40001-023-01512-w","article-title":"The FDA-approved anti-amyloid-\u03b2 monoclonal antibodies for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Wu","year":"2023","journal-title":"Eur J Med Res"},{"key":"B15","author":"Adams","year":""},{"key":"B16","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/s24051572","article-title":"Machine learning and digital biomarkers can detect early stages of neurodegenerative diseases","volume":"24","author":"Chudzik","year":"2024","journal-title":"Sensors"},{"key":"B17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41746-025-01640-z","article-title":"Alzheimer\u2019s disease digital biomarkers multidimensional landscape and AI model scoping review","volume":"8","author":"Qi","year":"2025","journal-title":"Npj Digit Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3233\/JAD-240327","article-title":"Digital biomarkers for the assessment of non-cognitive symptoms in patients with dementia with lewy bodies: a systematic review","volume":"100","author":"Sjaelland","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"100070","DOI":"10.1016\/j.aggp.2024.100070","article-title":"A cognitive function test utilizing eye-tracking technology in virtual reality is useful to distinguish between normal cognition, MCI and mild dementia","volume":"1","author":"Mizukami","year":"2024","journal-title":"Arch Gerontol Geriatr Plus"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1080\/13607863.2025.2464704","article-title":"Insights from the eyes: a systematic review and meta-analysis of the intersection between eye-tracking and artificial intelligence in dementia","volume":"29","author":"Norouzi","year":"2025","journal-title":"Aging Ment Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41746-024-01206-5","article-title":"A portable and efficient dementia screening tool using eye tracking machine learning and virtual reality","volume":"7","author":"Xu","year":"2024","journal-title":"Npj Digit Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/ohn.830","article-title":"Voice as a biomarker in health-tech: mapping the evolving landscape of voice biomarkers in the start-up world","volume":"171","author":"Evangelista","year":"2024","journal-title":"Otolaryngol Neck Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e12393","DOI":"10.1002\/dad2.12393","article-title":"Development of digital voice biomarkers and associations with cognition, cerebrospinal biomarkers, and neural representation in early Alzheimer\u2019s disease","volume":"15","author":"Hajjar","year":"2023","journal-title":"Alzheimers Dement"},{"key":"B24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3233\/JAD-180037","article-title":"A prototype for the voice analysis diagnosis of Alzheimer\u2019s disease","volume":"64","author":"Mart\u00ednez-S\u00e1nchez","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41746-021-00470-z","article-title":"Using a digital neuro signature to measure longitudinal individual-level change in Alzheimer\u2019s disease: the altoida large cohort study","volume":"4","author":"Meier","year":"2021","journal-title":"Npj Digit Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1038\/s41467-018-05892-0","article-title":"Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with subtype and stage inference","volume":"9","author":"Young","year":"2018","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s43587-024-00599-y","article-title":"Disease staging of Alzheimer\u2019s disease using a CSF-based biomarker model","volume":"4","author":"Salvad\u00f3","year":"2024","journal-title":"Nat Aging"},{"key":"B28","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","article-title":"Brain \u03b2-amyloid load approaches a plateau","volume":"80","author":"Jack","year":"2013","journal-title":"Neurology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaneurol.2021.1858","article-title":"Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: a head-to-head comparison against amyloid positron emission tomography and magnetic resonance imaging","volume":"78","author":"Ossenkoppele","year":"2021","journal-title":"JAMA Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"104450","DOI":"10.1016\/j.ebiom.2023.104450","article-title":"Rates of regional tau accumulation in ageing and across the Alzheimer\u2019s disease continuum: an AIBL 18F-MK6240 PET study","volume":"88","author":"Krishnadas","year":"2023","journal-title":"EBioMedicine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1001\/jama.2019.7437","article-title":"Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia","volume":"321","author":"Jack","year":"2019","journal-title":"JAMA"},{"key":"B32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13195-024-01410-1","article-title":"The role of perfusion, grey matter volume and behavioural phenotypes in the data-driven classification of cognitive syndromes","volume":"16","author":"Vipin","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"B33","author":"Yang","year":""},{"key":"B34","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1038\/s41598-019-39809-8","article-title":"Lifespan changes of the human brain in Alzheimer\u2019s disease","volume":"9","author":"Coup\u00e9","year":"2019","journal-title":"Sci Rep"},{"key":"B35","author":"Wen","year":""},{"key":"B36","doi-asserted-by":"publisher","first-page":"116456","DOI":"10.1016\/j.neuroimage.2019.116456","article-title":"Evaluating the reliability of neurocognitive biomarkers of neurodegenerative diseases across countries: a machine learning approach","volume":"208","author":"Bachli","year":"2020","journal-title":"NeuroImage"},{"key":"B37","doi-asserted-by":"publisher","first-page":"046048","DOI":"10.1088\/1741-2552\/ac87d0","article-title":"Multi-feature computational framework for combined signatures of dementia in underrepresented settings","volume":"19","author":"Moguilner","year":"2022","journal-title":"J Neural Eng"},{"key":"B38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijpsycho.2021.12.008","article-title":"Dementia ConnEEGtome: towards multicentric harmonization of EEG connectivity in neurodegeneration","volume":"172","author":"Prado","year":"2022","journal-title":"Int J Psychophysiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41583-023-00779-6","article-title":"Data-driven modelling of neurodegenerative disease progression: thinking outside the black box","volume":"25","author":"Young","year":"2024","journal-title":"Nat Rev Neurosci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1016\/S2589-7500(22)00029-2","article-title":"Explainability and artificial intelligence in medicine","volume":"4","author":"Reddy","year":"2022","journal-title":"Lancet Digit Health"},{"key":"B41","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13195-023-01304-8","article-title":"Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer\u2019s disease","volume":"15","author":"Blanco","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"B42","doi-asserted-by":"publisher","first-page":"0071","DOI":"10.34133\/icomputing.0071","article-title":"Cycle-consistency-based uncertainty quantification of neural networks in inverse imaging problems","volume":"2","author":"Huang","year":"2023","journal-title":"Intell Comput"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/3561048","article-title":"Explainable AI (XAI): core ideas, techniques, and solutions","volume":"55","author":"Dwivedi","year":"2023","journal-title":"ACM Comput Surv"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/3670685","article-title":"A practical tutorial on explainable AI techniques","volume":"57","author":"Bennetot","year":"2025","journal-title":"ACM Comput Surv"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1508686","DOI":"10.3389\/fdgth.2025.1508686","article-title":"Redefining and solving the digital divide and exclusion to improve healthcare: going beyond access to include availability, adequacy, acceptability, and affordability","volume":"7","author":"Hollimon","year":"2025","journal-title":"Front Digit Health"},{"key":"B46","doi-asserted-by":"publisher","first-page":"eadq4994","DOI":"10.1126\/science.adq4994","article-title":"The value of decentralized clinical trials: inclusion, accessibility, and innovation","volume":"385","author":"Jean-Louis","year":"2024","journal-title":"Science"},{"key":"B47","doi-asserted-by":"publisher","first-page":"7115","DOI":"10.3390\/ijerph20237115","article-title":"Precision recruitment and engagement of individuals at risk for diabetes and hypertension in clinical trials (PREDHICT): a randomized trial for an E-persuasive mobile application to inform decision making about clinical trials","volume":"20","author":"Seixas","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e16429","DOI":"10.2196\/16429","article-title":"A pantheoretical framework to optimize adherence to healthy lifestyle behaviors and medication adherence: the use of personalized approaches to overcome barriers and optimize facilitators to achieve adherence","volume":"8","author":"Seixas","year":"2020","journal-title":"JMIR MHealth UHealth"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e67485","DOI":"10.2196\/67485","article-title":"AI For IMPACTS framework for evaluating the long-term real-world impacts of AI-powered clinician tools: systematic review and narrative synthesis","volume":"27","author":"Jacob","year":"2025","journal-title":"J Med Internet Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41746-023-00978-6","article-title":"Augmented reality versus standard tests to assess cognition and function in early Alzheimer\u2019s disease","volume":"6","author":"Muurling","year":"2023","journal-title":"Npj Digit Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2196\/games.2778","article-title":"Ecological validity of virtual reality daily living activities screening for early dementia: longitudinal study","volume":"1","author":"Tarnanas","year":"2013","journal-title":"JMIR Serious Games"},{"key":"B52","doi-asserted-by":"publisher","first-page":"eaaz2387","DOI":"10.1126\/sciadv.aaz2387","article-title":"A\u03b2 deposition is associated with increases in soluble and phosphorylated tau that precede a positive tau PET in Alzheimer\u2019s disease","volume":"6","author":"Mattsson-Carlgren","year":"2020","journal-title":"Sci Adv"},{"key":"B53","author":"Zhang","year":""},{"key":"B54","doi-asserted-by":"publisher","first-page":"eaba1394","DOI":"10.1126\/sciadv.aba1394","article-title":"Unmasking selective path integration deficits in Alzheimer\u2019s disease risk carriers","volume":"6","author":"Bierbrauer","year":"2020","journal-title":"Sci Adv"},{"key":"B55","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/alz.12031","article-title":"Spatial navigation ability predicts progression of dementia symptomatology","volume":"16","author":"Levine","year":"2020","journal-title":"Alzheimers Dement"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1002\/alz.13733","article-title":"Entorhinal-based path integration selectively predicts midlife risk of Alzheimer\u2019s disease","volume":"20","author":"Newton","year":"2024","journal-title":"Alzheimers Dement"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e861","DOI":"10.1212\/WNL.0000000000008758","article-title":"Real-space navigation testing differentiates between amyloid-positive and -negative aMCI","volume":"94","author":"Sch\u00f6berl","year":"2020","journal-title":"Neurology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e336","DOI":"10.1016\/S2666-7568(24)00033-3","article-title":"The time course of motor and cognitive decline in older adults and their associations with brain pathologies: a multicohort study","volume":"5","author":"Oveisgharan","year":"2024","journal-title":"Lancet Healthy Longev"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/S2666-7568(23)00019-3","article-title":"The prevalence, correlation, and co-occurrence of neuropathology in old age: harmonisation of 12 measures across six community-based autopsy studies of dementia","volume":"4","author":"Nichols","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1038\/s43587-025-00977-0","article-title":"An international working group viewpoint on stratifying risk and prevention of the clinical expression of Alzheimer\u2019s disease","volume":"5","author":"Feldman","year":"2025","journal-title":"Nat Aging"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(25)01294-2","article-title":"New landscape of the diagnosis of Alzheimer\u2019s disease","volume":"406","author":"Frisoni","year":"2025","journal-title":"Lancet"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s43587-023-00471-5","article-title":"A two-step workflow based on plasma p-tau217 to screen for amyloid \u03b2 positivity with further confirmatory testing only in uncertain cases","volume":"3","author":"Brum","year":"2023","journal-title":"Nat Aging"},{"key":"B63","volume-title":"BEST (Biomarkers, EndpointS, and Other Tools) Resource","year":"2016"}],"container-title":["Frontiers in Digital Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2025.1727707\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:13:29Z","timestamp":1768205609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2025.1727707\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":63,"alternative-id":["10.3389\/fdgth.2025.1727707"],"URL":"https:\/\/doi.org\/10.3389\/fdgth.2025.1727707","relation":{},"ISSN":["2673-253X"],"issn-type":[{"value":"2673-253X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1727707"}}